People | June 13, 2025
Sun Pharma appoints Kirti Ganorkar as the Managing Director
Dilip Shanghvi to continue as the Executive Chairman of the Board
Dilip Shanghvi to continue as the Executive Chairman of the Board
Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
The acquisition is subject to customary closing conditions and necessary regulatory approvals. The financial terms of the transaction are confidential
Subscribe To Our Newsletter & Stay Updated
